Phase Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Phase Genomics's estimated annual revenue is currently $5.9M per year.
- Phase Genomics's estimated revenue per employee is $155,000
Employee Data
- Phase Genomics has 38 Employees.
- Phase Genomics grew their employee count by 23% last year.
Phase Genomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CTO | Reveal Email/Phone |
2 | Founder & CEO | Reveal Email/Phone |
3 | COO | Reveal Email/Phone |
4 | VP Business Development | Reveal Email/Phone |
5 | VP Research and Development | Reveal Email/Phone |
6 | Data Scientist | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | Product Marketing Manager | Reveal Email/Phone |
9 | Senior Product Manager | Reveal Email/Phone |
10 | Software Engineer II | Reveal Email/Phone |
Phase Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $258.5M | 898 | -10% | $1.1B | $2.4B |
What Is Phase Genomics?
Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. They offer a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples as well as industry-leading genome and metagenome assembly and analysis software. Founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs, the company's mission is to empower scientists with state-of-the-art genomic tools that will accelerate breakthrough discoveries. The company serves academic and commercial researchers in diverse fields and industries.
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.9M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Phase Genomics News
This table compares Denali Therapeutics and Quantum Genomics Société ... The company also develops DNL310 that is in Phase I/II clinical...
Genomic Consortium Diversifies Data, Explores Genomics of Body ... the globe and we look forward to seeing this through to the next phase.
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.4M | 38 | -10% | N/A |
#2 | $8.2M | 38 | -17% | N/A |
#3 | $4.2M | 38 | -25% | $4M |
#4 | $4.4M | 38 | N/A | N/A |
#5 | $7.4M | 38 | 15% | N/A |